Green tea compounds inhibit tyrosine phosphorylation of PDGF β-receptor and transformation of A172 human glioblastoma

FEBS Letters

Volumn 471, Issue 1, 2000, Pages 51-55

  Sachinidis, Agapios ^a   Seul, Claudia ^a   Seewald, Stefan ^a   Ahn, Hee Yul ^a   Ko, Yon ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

A172 glioblastoma; Catechin; PDGF R ; PI 3' K; PLC 1; Tumorigenicity

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL TRANSFORMATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG STRUCTURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TEA;

CATECHIN; CELL TRANSFORMATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TEA; TYROSINE;

EID: 0034616261     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01360-0     Document Type: Article

References (28)

1. Kohlmeier L., Weterings K.G., Steck S., Kok F.J. Nutr. Cancer. 27:1997;1-13.
2. Blot W.J., McLaughlin J.K., Chow W.H. Crit. Rev. Food Sci. Nutr. 37:1997;739-760.
3. Dreosti, I.E., Wargovich, M.J. and Yang, C.S. (1997) Crit. Rev. Food Sci. Nutr. 37, 761-770.
4. Yang C.S., Yang G.Y., Landau J.M., Kim S., Liao J. Exp. Lung Res. 24:1998;629-639.
5. Yang G., Wang Z.Y., Kim S., Liao J., Seril D.N., Chen X., Smith T.J., Yang C.S. Cancer Res. 57:1997;1889-1894.
6. Jankun J., Selman S.H., Swiercz R. Nature. 387:1997;561.
7. Cao Y., Cao R. Nature. 398:1999;381.
8. Ahn H.Y., Hadizadeh K.R., Seul C., Yun Y.P., Vetter H., Sachinidis A. Mol. Biol. Cell. 10:1999;1093-1104.
9. Kovalenko M., Gazit A., Böhmer A., Rorsman C., Rönnstrand L., Heldin C.-H., Waltenberger J., Böhmer F.-D., Levitzky A. Cancer Res. 54:1994;6106-6114.
10. Levitzki A., Gazit A. Science. 267:1995;1782-1788.
11. Rönnstrand L., Mori S., Arridson A.K., Erikssen A., Wernstedt C., Hellman U., Claesson-Welsh L., Heldin C.H. EMBO J. 11:1992;3911-3919.
12. Kaplan D.R., Morrison D.K., Wong G., McCormic F., Williams L. Cell. 61:1990;125-133.
13. Pelech S.L., Sanghera S. Science. 257:1992;1355-1356.
14. Freedman V.H., Shin S.I. Cell. 4:1974;355-359.
15. Westermark B., Heldin C.-H., Nistér M. Glia. 15:1995;257-263.
16. Vassbotn F.S., Östman A., Langeland N., Holmsen H., Westermark B., Heldin C.-H., Nistér M. J. Cell Physiol. 158:1994;381-389.
17. Hoppe J., Weich H.A., Eichner W. Biochemistry. 28:1989;2956-2960.
18. Seewald S., Seul C., Kettenhofen R., Bokemeyer D., Ko Y., Vetter H., Sachinidis A. Hypertension. 31:1998;1151-1156.
19. Balentine D.A., Wiseman S.A., Bouwens L.C. Crit. Rev. Food Sci. Nutr. 37:1997;693-704.
20. Yang C.S. Nature. 389:1997;134-135.
21. Hursting S.D., Slaga T.J., Fischer S.M., DiGiovanni J., Phang J.M. J. Natl. Cancer Inst. 91:1999;215-225.
22. Hunter T. Cell. 88:1997;333-346.
23. Bronzert D.A., Pantazis P., Antoniades H.N., Kasid A., Davidson N., Dickson R.B., Lippman M.E. Proc. Natl. Acad. Sci. USA. 84:1987;5763-5767.
24. Hsu S., Huang F., Friedman E. J. Cell Physiol. 165:1995;239-245.
25. Harsh G.R., Keating M.T., Escobedo J.A., Williams L.T. J. Neurooncol. 8:1990;1-12.
26. Shawver L.K., Schwartz D.P., Mann E., Chen H., Tsai J., Chu L., Taylorson L., Longhi M., Meredith S., Germain L., Jacobs J.S., Tang C., Ullrich A., Berens M.E., Hersh E., McMahon G., Hirth K.P., Powell T.J. Clin. Cancer Res. 3:1997;1167-1177.
27. Guan K.L., Broyles S.S., Dixon J.E. Nature. 350:1991;359-362.
28. Bokemeyer D., Sorokin A., Yan M., Ahn N.G., Templeton D.J., Dunn M.J. J. Biol. Chem. 271:1996;639-642.